DK3288955T3 - Bortezomib-baseret afgivelsessystem - Google Patents

Bortezomib-baseret afgivelsessystem Download PDF

Info

Publication number
DK3288955T3
DK3288955T3 DK16733715.3T DK16733715T DK3288955T3 DK 3288955 T3 DK3288955 T3 DK 3288955T3 DK 16733715 T DK16733715 T DK 16733715T DK 3288955 T3 DK3288955 T3 DK 3288955T3
Authority
DK
Denmark
Prior art keywords
bortezomib
delivery system
based delivery
delivery
Prior art date
Application number
DK16733715.3T
Other languages
English (en)
Inventor
Luigi Pasqua
Antonella Leggio
Angelo Liguori
Catia Morelli
Sebastino Andò
Original Assignee
Nanosilical Devices Srl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nanosilical Devices Srl filed Critical Nanosilical Devices Srl
Application granted granted Critical
Publication of DK3288955T3 publication Critical patent/DK3288955T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/695Silicon compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6921Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a particulate, a powder, an adsorbate, a bead or a sphere
    • A61K47/6923Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a particulate, a powder, an adsorbate, a bead or a sphere the form being an inorganic particle, e.g. ceramic particles, silica particles, ferrite or synsorb
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D241/00Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/10Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D241/12Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00Compounds containing elements of Groups 4 or 14 of the Periodic System
    • C07F7/02Silicon compounds
    • C07F7/08Compounds having one or more C—Si linkages
    • C07F7/18Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00Compounds containing elements of Groups 4 or 14 of the Periodic System
    • C07F7/02Silicon compounds
    • C07F7/08Compounds having one or more C—Si linkages
    • C07F7/18Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804Compounds having Si-O-C linkages
DK16733715.3T 2015-04-29 2016-04-29 Bortezomib-baseret afgivelsessystem DK3288955T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ITRM20150184 2015-04-29
PCT/IT2016/000111 WO2016174693A1 (en) 2015-04-29 2016-04-29 Bortezomib-based delivery system

Publications (1)

Publication Number Publication Date
DK3288955T3 true DK3288955T3 (da) 2020-01-02

Family

ID=53765345

Family Applications (1)

Application Number Title Priority Date Filing Date
DK16733715.3T DK3288955T3 (da) 2015-04-29 2016-04-29 Bortezomib-baseret afgivelsessystem

Country Status (14)

Country Link
US (1) US10239897B2 (da)
EP (1) EP3288955B1 (da)
CN (1) CN107660210B (da)
AU (1) AU2016255738B2 (da)
BR (1) BR112017023250B1 (da)
CA (1) CA2985311A1 (da)
DK (1) DK3288955T3 (da)
ES (1) ES2762989T3 (da)
HK (1) HK1250370A1 (da)
HU (1) HUE047207T2 (da)
PL (1) PL3288955T3 (da)
PT (1) PT3288955T (da)
RU (1) RU2727156C2 (da)
WO (1) WO2016174693A1 (da)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108421043B (zh) * 2018-02-11 2021-03-26 华东师范大学 一种可示踪的硼酸类纳米药物复合物及其制备方法和用途
CN113038968A (zh) * 2018-06-01 2021-06-25 Tae生命科学有限责任公司 用于中子捕获疗法的可生物降解纳米载体(bpmo)和其方法
CN109045272A (zh) * 2018-08-01 2018-12-21 厦门市壳聚糖生物科技有限公司 一种硼替佐米磷脂复合物及其制备方法与应用
CN108635590B (zh) * 2018-08-15 2021-05-18 内蒙古农业大学 一种pH响应的多糖–硼替佐米纳米球及其制备方法和应用
CN109439723A (zh) * 2018-11-30 2019-03-08 王瑞明 一种多层纳米复合粒子的毒性测试方法
CN114555610A (zh) 2019-05-20 2022-05-27 麻省理工学院 硼酸酯前药及其用途
CN113444288B (zh) * 2021-06-10 2022-06-07 南昌工程学院 一种具有可逆交联结构的二氧杂硼烷基团修饰钛酸钡及其制备方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9061037B2 (en) * 2010-03-18 2015-06-23 Innopharma, Inc. Stable bortezomib formulations
CA2909519A1 (en) * 2013-04-16 2014-10-23 Cipla Limited Process for the preparation of bortezomib mannitol ester

Also Published As

Publication number Publication date
ES2762989T3 (es) 2020-05-26
CN107660210A (zh) 2018-02-02
AU2016255738B2 (en) 2020-10-15
BR112017023250B1 (pt) 2023-09-26
EP3288955B1 (en) 2019-09-18
US10239897B2 (en) 2019-03-26
WO2016174693A1 (en) 2016-11-03
PL3288955T3 (pl) 2020-04-30
RU2017135265A3 (da) 2019-08-29
EP3288955A1 (en) 2018-03-07
PT3288955T (pt) 2020-01-06
RU2727156C2 (ru) 2020-07-21
CN107660210B (zh) 2020-07-03
HUE047207T2 (hu) 2020-04-28
US20180127441A1 (en) 2018-05-10
HK1250370A1 (zh) 2018-12-14
AU2016255738A1 (en) 2017-10-26
RU2017135265A (ru) 2019-04-08
BR112017023250A2 (pt) 2018-08-07
CA2985311A1 (en) 2016-11-03

Similar Documents

Publication Publication Date Title
DK3283625T3 (da) Nukleasemedieret genomeditering
DK3265421T3 (da) Doseringssystem
DK3200886T3 (da) Spilsystem
DK3305788T3 (da) Janus-kinase-hæmmer
DK3313490T3 (da) Slangesystem
DK3277719T3 (da) Polypeptider
DK3356633T3 (da) Taper-loc-systemforbedringer
DK3171701T3 (da) Infusionsanlæg
DK3270930T3 (da) Præeklampsi
DK3161247T3 (da) Brøndsystem
DK3296597T3 (da) Krydshovedmotor
DK3288955T3 (da) Bortezomib-baseret afgivelsessystem
DK3272129T3 (da) Kommunikationssystem
DK3292136T3 (da) Penicillin-g-acylaser
DK3276177T3 (da) Spiralhuspumpe
DE112016001783A5 (de) Kupplungssystem
DE112016001782A5 (de) Kupplungssystem
DK3362354T3 (da) Tilbagetrækkeligt propelsystem
DE112015006486A5 (de) Inkubationsrinne
DK3234271T3 (da) Gelændersystem
FR3040689B1 (fr) Drone aeroterrestre de livraison
DE112016005599A5 (de) Strahlungsgrill
DK3276178T3 (da) Spiralhuspumpe
DE112015005906A5 (de) Gurtschlossbringer
DE102015206660A8 (de) Plattenaufteilanlage